Jan 07, 2021
'Custom-Made' Accounts for 2 out of 3 Sales of Foot Orthotic Insoles: Report
by Team Fact.MR
Demand for foot orthotic insoles is set to rise steadily through 2030, with ‘custom-made’ capturing bulk of the sales, as per a new report by Fact.MR. Consumer preference for insoles that offer convenience and comfort is likely to drive manufacturers to offer more customized solutions. Over the long run, demand is likely to be influenced by a steadily rising geriatric and diabetic population.
Key foot orthotic insoles manufacturers are focusing on collaborative manufacturing to expand their share in high-growth markets. The marketplace remains highly fragmented, with a large number of small players operating across all regions. Moreover, increasing sales through online platforms will boost the growth of the global foot orthotic insoles market. e-ommerce platforms allow customers to browse and order from a range of product offerings provided by vendors. It makes the shopping experience of easier and supports brand retaining and promotion. As per Fact.MR analysis, the global foot orthotic insoles market is projected to be valued at US$ 7.4 Bn in 2030.
- Custom foot orthotic insoles account for over 60% of total revenues
- Polyethylene foam foot orthotic insoles are most sought-after by manufacturers
- Demand for medical industry remains mainstay, but growing use among athletes is creating new revenue streams
- US, UK, Germany, France, Spain, and Italy collectively hold over 50% market share
- Purchases through hospitals & specialty clinics continues to be the most lucrative sales channel
- The COVID 19 pandemic impact on foot orthotic sales have been relatively less severe.
“As customization is a key consumer requirement, manufacturers need to offer the right technology and offline channels to consolidate their position. ,” says a Fact.MR analyst.
Product Portfolio Expansion & Partnerships - Key Strategies Followed by Market Players
Dr Scholl’s, Powerstep, Superfeet Worldwide, Inc., Bauerfeind, and A. Algeo Limited contribute a high market value share of around 20% in global foot orthotic insoles market. Foot orthotic insole manufacturers are focusing on expansion of their product portfolios. For instance, in July 2019, Yellow Wood Partners entered into a definitive agreement to buy Dr Scholl’s™ business from Bayer for a purchase price of US$ 585 million.
Looking for More Information?
The research study on the foot orthotic insoles market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape over 2015–2019, and includes detailed assessment of key parameters that are anticipated to exert influence from 2020 to 2030. Market statistics have been presented based on product (prefabricated and customized), application (sports & athletics, medical prescribed, and personal comfort), material (gel, ethyl-vinyl acetates, thermoplastics, polyethylene foams, composite carbon fibres, leather, cork, and others), user (adults and paediatrics), and distribution channel (hospitals & specialty clinics, drug stores, online stores, and others), across major regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
About Fact.MR’s Healthcare Division
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions. For more information on our deep domain expertise, click here.